Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Selpercatinib (LOXO-292) is a tyrosine kinase inhibitor with antineoplastic properties(IC50 of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M) , and RET (G810R), respectively)
説明 | Selpercatinib (LOXO-292) is a tyrosine kinase inhibitor with antineoplastic properties(IC50 of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M) , and RET (G810R), respectively) |
ターゲット&IC50 | RET (V804M):24.1 nM , RET (G810R):530.7 nM, RET (WT):14.0 nM |
別名 | LOXO-292 |
分子量 | 525.6 |
分子式 | C29H31N7O3 |
CAS No. | 2152628-33-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 8.33 mg/mL (15.85 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Selpercatinib 2152628-33-4 Apoptosis Tyrosine Kinase/Adaptors c-RET FVB/NRj mice RET (WT) inhibit Inhibitor RET (G810R) RET (V804M) LOXO 292 LOXO292 RET anticancer LOXO-292 inhibitor